Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/2275

Title:	Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.
Authors:	Tural, Deniz Arslan, Cagatay Selcukbiricik, Fatih Olmez, Omer Fatih Erman, Mustafa Urun, Yuksel Karadurmus, Nuri
Publisher:	Lippincott Williams & Wilkins
Abstract:	[Abstract Not Available]
URI:	https://doi.org/10.1200/JCO.2022.40.6_suppl.474 https://hdl.handle.net/20.500.14365/2275
ISSN:	0732-183X 1527-7755
Appears in Collections:	WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

CORE Recommender

64

checked on Nov 25, 2024

Check